Generics 20

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Theophylline anhydrous manufacturers

20 products found

Filters

20 products found

theophylline anhydrous

Tablets, delayed release (DR) 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17633
In the 1950s, the pharmaceutical laboratory was established. Its first manufacturing facility for inhalation aerosols was established in the 1960s, making it one of the first companies to introduce such a product to the market. It was one of the first firms in the world to sell silver sulfadiazine as a pharmaceutical product in cream and aerosol form.

Manufacturer usually replies in 9 days

theophylline anhydrous

Solution for injection 240 mg/4 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Distribution only
Manufacturer #2110
A pharmaceutical manufacturer based in the EU that has been active for 50+ years. The company's production lines are GMP-compliant. Key production lines are Rx and OTC. Main therapeutic areas include the cardiovascular system, CNS, and diabetes. Main dosage forms include solid, liquid, semi-solid and injectable forms.

Manufacturer usually replies in 6 days

theophylline anhydrous

Tablets, modified release (MR) 100 mg, 200 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Distribution only
Manufacturer #2110
A pharmaceutical manufacturer based in the EU that has been active for 50+ years. The company's production lines are GMP-compliant. Key production lines are Rx and OTC. Main therapeutic areas include the cardiovascular system, CNS, and diabetes. Main dosage forms include solid, liquid, semi-solid and injectable forms.

Manufacturer usually replies in 6 days

theophylline anhydrous

Solution for infusion 200 mg/100 ml, 400 mg/500 ml - 100 ml, 500 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS, EU GMP
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

theophylline anhydrous

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #21264
It was established in the 1970s. To uphold a mission of human health improvement, the company focuses on people's needs, assembling experts in the medical area, and being devoted to the research and development of high-barrier generic drugs and healthcare products. All of the health/medical products are broadly used in various medical institutions. After 40 years of striving for constant technique improvement. The company has become one of the most trustworthy partners.

Manufacturer usually replies in 1 days

theophylline anhydrous

Tablets, modified release (MR) 200mg, 300mg, 400mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Unavailable markets
Germany
Manufacturer #11630

Manufacturer usually replies in 4 days

theophylline anhydrous

Oral solution 5.34 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20576
The company is focused to produce good quality products for more than 50 years. The company believes that pharmaceutical work and product development can help improve the quality of life of people, no matter where they live. Poverty or wealth; health is priceless, they are duty-bound.

Manufacturer usually replies in 6 days

theophylline anhydrous

Tablets 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

theophylline anhydrous

Capsules 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, EU GMP
Manufacturer #20767
It is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. They have a broad technology base covering OSD, liquids, creams, ointments, and sterile (injectable) across all key therapeutic areas. They have a further 90+ products (INNs) under development and registration. They aim to improve the quality of life by increasing access to high-quality and affordable medicines.

Manufacturer usually replies in 11 days

theophylline anhydrous

Tablets 250 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Singapore
GMP approvals
PICS
Manufacturer #20928
It is celebrating over 50 years of continued success. It is one of the largest manufacturers of generic pharmaceuticals and provides a comprehensive suite of fully integrated "one-stop" contract manufacturing solutions. It owns and operates in more than one PIC/S GMP-certified manufacturing facility.

Manufacturer usually replies in 23 days

theophylline anhydrous

Tablets 100, 200, 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Israel
Manufacturer #9206
It specializes in the development, manufacturing, and marketing of pharmaceutical products. The portfolio of the company including Rx and OTC drugs in a wide variety of forms, includes tablets, capsules, creams, gels, ointments, powders, syrups, and sprays. The company has only one vision of an evolving and progress-seeking pharmaceutical company working on creativity for a healthier tomorrow.

Manufacturer usually replies in 17 days

theophylline anhydrous + salbutamol sulfate

Tablets 100 mg + 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20058

theophylline anhydrous

Tablets, modified release (MR) 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
Manufacturer #274

theophylline anhydrous

Suppositories 100mg, 300mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
Manufacturer #274

theophylline anhydrous

Capsules, modified release (MR) 100mg, 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
Manufacturer #274

salbutamol sulfate + theophylline anhydrous

Tablets 1 mg + 130 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20691

Manufacturer usually replies in 4 days

salbutamol sulfate + theophylline anhydrous

Syrup 0.5 mg + 50 mg, 1 mg + 130 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20656

Manufacturer usually replies in 2 days

salbutamol + theophylline anhydrous

Tablets 2 mg+100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19278

ephedrine hydrochloride + theophylline anhydrous + magnesium trisilicate

Tablets 30 mg + 80 mg + 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18366

salbutamol sulfate + theophylline anhydrous

Tablets 1 mg + 130 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
GMP, Indonesia
Manufacturer #28188

Want to view all 20 products? Create your free account today!

Theophylline Anhydrous Manufacturer

Theophylline Anhydrous is sold under trade names “Theolair” and “Slo-Bid”. It is classified under Phosphodiesterase inhibiting drugs. It is used to treat apnea of premature infants, respiratory disease, chronic obstructive pulmonary disease, and asthma. It is administered through oral, intramuscular, and rectal routes. It is 100 percent bioavailable when taken orally. It is metabolized by 1-methyluric acid in the liver and its elimination half-life is 5-8 hours. This pharmaceutical medicine has a narrow therapeutic window and the toxicity range is high. Drug interactions are with benzodiazepines, acyclovir, abametapir, abiraterone, acebutolol, acetaminophen, and acetazolamide. It is contraindicated in conditions like overactive thyroid gland, diabetes, cystic fibrosis, alcoholism, hypertension, and angina. Side effects associated with this pharmaceutical medicine include diarrhea, abnormal heart rhythms, CNS excitations, and seizures. It is categorized by the FDA as a category C drug for pregnancy and by TGA as a category A drug for pregnancy. This medication should only be used when necessary while pregnant. The amount of this medication in your blood may be affected by changes in your body during the final three months of pregnancy. Any side effects should be closely monitored by your doctor so that your dosage can be adjusted if necessary. This medication is secreted in breast milk and could harm a nursing baby, hence there are no recommendations for its use by lactating women.

How does Theophylline Anhydrous work?

It works by inhibiting phosphodiesterase type 3 and 4 which results in smooth muscle relaxing by the breakdown of cyclic AMP. It also blocks adenosine-mediated bronchoconstriction.

The cost of Theophylline Anhydrous

For a bulk supply of 100 tablets of Theophylline extended-release oral tablets 400 mg/24 hours, it costs around 94 dollars. This price may fluctuate from seller to seller.

Sourcing the Theophylline Anhydrous Manufacturers and Suppliers

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Theophylline Anhydrous offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Theophylline Anhydrous Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Theophylline Anhydrous is already registered in. The suppliers and manufacturers also have special delivery terms.

Establishing commercial ties

Pipelinepharma is a pharmaceutical medicine licensing marketplace that connects investors with customers quickly for business development. Product names can be filtered by country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more in a user-friendly and unified search engine.

Quality assurance

Pipelinepharma is a reliable online platform for pharmaceuticals. The site thoroughly examines the product's quality, duration of use, and seller details. To ensure that medicines are safe and reliable for consumers, all of them are thoroughly examined for any possible flaws before being advertised, and the information about the sellers is evaluated as part of the registration process.